In vivointranasal delivery of coagulation factor IX: a proof-of-concept study

التفاصيل البيبلوغرافية
العنوان: In vivointranasal delivery of coagulation factor IX: a proof-of-concept study
المؤلفون: Fieux, Maxime, Rovera, Renaud, Coiffier, Céline, Colomb, Evelyne, Enjolras, Nathalie, Béquignon, Emilie, Monge, Claire, Le Quellec, Sandra
المصدر: Journal of Thrombosis and Haemostasis; November 2023, Vol. 21 Issue: 11 p3117-3123, 7p
مستخلص: Hemophilia B (HB) is a bleeding disorder characterized by coagulation factor (F) IX (FIX) deficiency. The current standard-of-care for severe HB is prophylaxis with long-term repetitive intravenous (i.v.) infusions of recombinant FIX (rFIX) with standard half-life or extended half-life. Unmet needs remain regarding the development of non-invasive administration routes for coagulation factors. The aim of this study was to evaluate the effectiveness of intranasal delivery (IND) of rFIX and rFIX fused to Fc fragment (rFIX-Fc) in mice.
قاعدة البيانات: Supplemental Index
الوصف
تدمد:15387933
15387836
DOI:10.1016/j.jtha.2023.08.019